New approaches for male fertility control: HE6 as an example of a putative target

Molecular and Cellular Endocrinology

Volumn 250, Issue 1-2, 2006, Pages 49-57

  Gottwald, Ulrich ^a   Davies, Ben ^b   Fritsch, Martin ^a   Habenicht, Ursula F ^a  

^a BAYER PHARMA AG   (Germany)

^b genOway GmbH   (Germany)

Author keywords

Drug targets; Efferent duct; Epididymis; GPR64; HE6; Knockout mouse; Male contraception

Indexed keywords

DISINTEGRIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR HE6; GONADOTROPIN; MALE CONTRACEPTIVE AGENT; METALLOPROTEINASE; PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BIRTH CONTROL; CONTRACEPTION; EJACULATION; EPIDIDYMIS; FEASIBILITY STUDY; FERTILIZATION; HUMAN; IMMUNOCONTRACEPTION; INFERTILITY; KNOCKOUT MOUSE; MALE; MALE FERTILITY; NONHUMAN; OOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCREENING; SPERM; SPERMATOGENESIS; SPERMATOZOON; SPERMATOZOON MOTILITY; TESTIS;

ANIMALS; CONTRACEPTION; CONTRACEPTIVE AGENTS, MALE; DRUG DESIGN; EPIDIDYMIS; FERTILITY; HUMANS; INFERTILITY, MALE; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, G-PROTEIN-COUPLED;

EID: 33646174353     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.12.024     Document Type: Article

References (42)

1. Amory J.K. Testosterone/progestin regimens: a realistic option for male contraception?. Curr. Opin. Invest. Drugs 5 (2004) 1025-1030
2. Berthet C., Aleem E., Coppola V., Tessarollo L., and Kaldis P. Cdk2 knockout mice are viable. Curr. Biol. 13 (2003) 1775-1785
3. Chen G., Way J., Armour S., Watson C., Queen K., Jayawickreme C.K., Chen W.J., and Kenakin T. Use of constitutive G protein-coupled receptor activity for drug discovery. Mol. Pharmacol. 57 (2000) 125-134
4. Clermont Y. Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal. Physiol. Rev. 52 (1972) 198-236
5. Cooper T.G. Role of the epididymis in mediating changes in the male gamete during maturation. Adv. Exp. Med. Biol. 377 (1995) 87-101
6. Davies B., Baumann C., Kirchhoff C., Ivell R., Nubbemeyer R., Habenicht U.F., Theuring F., and Gottwald U. Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility. Mol. Cell. Biol. 24 (2004) 8642-8648
7. Diczfalusy E., Fathalla M., Habenicht U.F., and Stock G. The AMPPA network as a successful model for public-private or private-private partnership. Mol. Cell. Endocrinol. 216 (2004) 1-4
8. DiMasi J.A., Hansen R.W., and Grabowski H.G. The price of innovation: new estimates of drug development costs. J. Health Econ. 22 (2003) 151-185
9. Egner U., Kratzschmar J., Kreft B., Pohlenz H.D., and Schneider M. The target discovery process. Chembiochem 6 (2005) 468-479
10. Esposito G., Jaiswal B.S., Xie F., Krajnc-Franken M.A., Robben T.J., Strik A.M., Kuil C., Philipsen R.L., van Duin M., Conti M., and Gossen J.A. Mice deficient for soluble adenylyl cyclase are infertile because of a severe sperm-motility defect. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2993-2998
11. Foord S.M., Jupe S., and Holbrook J. Bioinformatics and type II G-protein-coupled receptors. Biochem. Soc. Trans. 30 (2002) 473-479
12. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63 (2003) 1256-1272
13. Heckel N.J. Production of oligospermia in a man by the use of testosterone propionate. Proc. Soc. Exp. Biol. Med. 40 (1939) 658-659
14. Heinemann K., Saad F., Wiesemes M., and Heinemann L.A. Expectations toward a novel male fertility control method and potential user types: results of a multinational survey. J. Androl. 26 (2005) 155-162
15. Hess R.A., Bunick D., Lee K.H., Bahr J., Taylor J.A., Korach K.S., and Lubahn D.B. A role for oestrogens in the male reproductive system. Nature 390 (1997) 509-512
16. Ivell R., Danner S., and Fritsch M. Post-meiotic gene products as targets for male contraception. Mol. Cell. Endocrinol. 216 (2004) 65-74
17. Johnston D.S., Jelinsky S.A., Bang H.J., Dicandeloro P., Wilson E., Kopf G.S., and Turner T.T. The murine epididymal transcriptome: transcriptional profiling of segmental gene expression in the epididymis. Biol. Reprod. 73 (2005) 404-413
18. Krasnoperov V.G., Bittner M.A., Beavis R., Kuang Y., Salnikow K.V., Chepurny O.G., Little A.R., Plotnikov A.N., Wu D., Holz R.W., and Petrenko A.G. Alpha-latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 18 (1997) 925-937
19. Lin Y.C., Sun G.H., Lee Y.M., Guo Y.W., and Liu H.W. Cloning and characterization of a complementary DNA encoding a human epididymis-associated disintegrin and metalloprotease 7 protein. Biol. Reprod. 65 (2001) 944-950
20. Livera G., Xie F., Garcia M.A., Jaiswal B., Chen J., Law E., Storm D.R., and Conti M. Inactivation of the mouse adenylyl cyclase 3 gene disrupts male fertility and spermatozoon function. Mol. Endocrinol. 19 (2005) 1277-1290
21. Martin C.W., Anderson R.A., Cheng L., Ho P.C., van der Spuy Z., Smith K.B., Glasier A.F., Everington D., and Baird D.T. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum. Reprod. 15 (2000) 637-645
22. Matzuk M.M., and Lamb D.J. Genetic dissection of mammalian fertility pathways. Nat. Cell Biol. 4 Suppl. (2002) s41-s49
23. McCullagh E.P., and McGurl F.J. Further observations on the clinical use of testosterone propionate. J. Urol. 42 (1939) 1265-1267
24. Miki K., Qu W., Goulding E.H., Willis W.D., Bunch D.O., Strader L.F., Perreault S.D., Eddy E.M., and O'Brien D.A. Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16501-16506
25. Nieschlag E., and Waites G.M. A male contraceptive pill. Nat. Med. 2 (1996) 722
26. Obermann H., Samalecos A., Osterhoff C., Schroder B., Heller R., and Kirchhoff C. HE6, a two-subunit heptahelical receptor associated with apical membranes of efferent and epididymal duct epithelia. Mol. Reprod. Dev. 64 (2003) 13-26
27. 2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J. Biol. Chem. 279 (2004) 33742-33750
28. O'Rand M.G., Widgren E.E., Sivashanmugam P., Richardson R.T., Hall S.H., French F.S., VandeVoort C.A., Ramachandra S.G., Ramesh V., and Jagannadha Rao A. Reversible immunocontraception in male monkeys immunized with eppin. Science 306 (2004) 1189-1190
29. Osterhoff C., Ivell R., and Kirchhoff C. Cloning of a human epididymis-specific mRNA, HE6, encoding a novel member of the seven transmembrane-domain receptor superfamily. DNA Cell Biol. 16 (1997) 379-389
30. Parnot C., Miserey-Lenkei S., Bardin S., Corvol P., and Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13 (2002) 336-343
31. Pasqualotto F.F., Lucon A.M., Sobreiro B.P., Pasqualotto E.B., and Arap S. The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal?. Rev. Hosp. Clin. Fac. Med. Sao Paulo 59 (2004) 312-315
32. Perheentupa A., and Huhtaniemi I. Male contraception - quo vadis?. Acta Obstet. Gynecol. Scand. 83 (2004) 131-137
33. Ren D., Navarro B., Perez G., Jackson A.C., Hsu S., Shi Q., Tilly J.L., and Clapham D.E. A sperm ion channel required for sperm motility and male fertility. Nature 413 (2001) 603-609
34. Quill T.A., Sugden S.A., Rossi K.L., Doolittle L.K., Hammer R.E., and Garbers D.L. Hyperactivated sperm motility driven by CatSper2 is required for fertilization. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14869-14874
35. 2+ ATPase 4 is required for sperm motility and male fertility. J. Biol. Chem. 279 (2004) 28220-28226
36. Spehr M., Gisselmann G., Poplawski A., Riffell J.A., Wetzel C.H., Zimmer R.K., and Hatt H. Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 299 (2003) 2054-2058
37. Spiridonov N.A., Wong L., Zerfas P.M., Starost M.F., Pack S.D., Paweletz C.P., and Johnson G.R. Identification and characterization of SSTK, a serine/threonine protein kinase essential for male fertility. Mol. Cell Biol. 25 (2005) 4250-4261
38. Trussell J., and Kost K. Contraceptive failure in the United States: a critical review of the literature. Stud. Fam. Plann. 18 (1987) 237-283
39. Wang C., and Swerdloff R.S. Male hormonal contraception. Am. J. Obstet. Gynecol. 190 Suppl. 4 (2004) S60-S68
40. Wise A., Gearing K., and Rees S. Target validation of G-protein coupled receptors. Drug Discov. Today 7 (2002) 235-246
41. Wu F.C. Male contraception. Bailliere Clin. Obstet. Gynaecol. 10 (1996) 1-23
42. Wu J.Y., Ribar T.J., Cummings D.E., Burton K.A., McKnight G.S., and Means A.R. Spermiogenesis and exchange of basic nuclear proteins are impaired in male germ cells lacking Camk4. Nat. Genet. 25 (2000) 448-452